SRC and osteosarcoma: Mechanistically, TGFBI propels cancer progression by activating αvβ5 integrin signaling, ultimately engaging Src, FAK, PI3K, and AKT through its RGD motif, as observed in models of osteosarcoma, colon, and pancreatic cancer12,14,15.